Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Retrovir 100mg capsules
0503010Y0BBAAAA
|
Retrovir | Zidovudine | Infections | No data available |
|
Retrovir 100mg/10ml oral solution
0503010Y0BBAEAD
|
Retrovir | Zidovudine | Infections | No data available |
|
Retrovir 250mg capsules
0503010Y0BBABAB
|
Retrovir | Zidovudine | Infections | No data available |
|
Retrovir IV 200mg/20ml concentrate for inf vials
0503010Y0BBAFAE
|
Retrovir | Zidovudine | Infections | No data available |
|
Reyataz 100mg capsules
0503010L0BBACAC
|
Reyataz | Atazanavir | Infections | No data available |
|
Reyataz 150mg capsules
0503010L0BBAAAA
|
Reyataz | Atazanavir | Infections | No data available |
|
Reyataz 200mg capsules
0503010L0BBABAB
|
Reyataz | Atazanavir | Infections | No data available |
|
Reyataz 300mg capsules
0503010L0BBADAD
|
Reyataz | Atazanavir | Infections | No data available |
|
Rezolsta 800mg/150mg tablets
0503010AKBBAAAA
|
Rezolsta | Darunavir/cobicistat | Infections | No data available |
|
Ribavirin 1.2g/12ml solution for injection vials
0503050B0AAAIAI
|
Ribavirin | Ribavirin | Infections | No data available |
|
Ribavirin 200mg tablets
0503050B0AAAEAE
|
Ribavirin | Ribavirin | Infections | No data available |
|
Ribavirin 400mg tablets
0503050B0AAAGAG
|
Ribavirin | Ribavirin | Infections | No data available |
|
Ribavirin 40mg/ml oral solution
0503050B0AAAHAH
|
Ribavirin | Ribavirin | Infections | No data available |
|
Ribavirin 6g powder for nebuliser solution vials
0503050B0AAAAAA
|
Ribavirin | Ribavirin | Infections | No data available |
|
Rifabutin 100mg/5ml oral liquid
0501090Q0AAAZAZ
|
Rifabutin | Rifabutin | Infections | No data available |
|
Rifabutin 150mg/5ml oral liquid
0501090Q0AAAUAU
|
Rifabutin | Rifabutin | Infections | No data available |
|
Rifabutin 50mg/5ml oral liquid
0501090Q0AAAJAJ
|
Rifabutin | Rifabutin | Infections | No data available |
|
Rifabutin 60mg/5ml oral liquid
0501090Q0AAAGAG
|
Rifabutin | Rifabutin | Infections | No data available |
|
Rifabutin 75mg/5ml oral liquid
0501090Q0AAALAL
|
Rifabutin | Rifabutin | Infections | No data available |
|
Rifabutin 90mg/5ml oral liquid
0501090Q0AAAVAV
|
Rifabutin | Rifabutin | Infections | No data available |
|
Rifadin 600mg inf vials
0501090R0BBAEAD
|
Rifadin | Rifampicin | Infections | No data available |
|
Rifampicin 120mg/5ml oral liquid
0501090R0AAAMAM
|
Rifampicin | Rifampicin | Infections | No data available |
|
Rifampicin 150mg/5ml oral liquid
0501090R0AAAKAK
|
Rifampicin | Rifampicin | Infections | No data available |
|
Rifampicin 200mg/5ml oral liquid
0501090R0AAANAN
|
Rifampicin | Rifampicin | Infections | No data available |
|
Rifampicin 210mg/5ml oral liquid
0501090R0AAAUAU
|
Rifampicin | Rifampicin | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.